• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[利用回归分析和判别分析对慢性阻塞性肺疾病患者肺动脉高压进行无创诊断]

[Noninvasive diagnosis of pulmonary hypertension in patients with COPD using regression and discriminant analysis].

作者信息

Franz H, Schauer J

机构信息

Klinik für Innere Medizin, Universität Leipzig.

出版信息

Z Gesamte Inn Med. 1993 Nov;48(11):538-43.

PMID:8291271
Abstract

The evidence of elevated non-invasive parameters in prediction of pulmonary hypertension was examined in 168 patients with chronic obstructive pulmonary disease (COPD). Forced vital capacity (FVC), Tiffeneau-test (FEV1), oxygen partial pressure, x-ray ascertained diameter of right descending branch of pulmonary artery (RDB), myocardial scintigraphy, and right ventricular ejection fraction showed significant differences between patients with and without pulmonary hypertension. Neither of them alone allows prediction of pulmonary pressure exactly, only in combination non-invasive parameters are usable. In non-invasive diagnosis of catheterisation we suggest to use a regression function including FEV1, FVC and RDB by an ascertained specificity of 80% and sensitivity of 75%. To classify the patients according to normal and increased pulmonary artery pressure, FEV1, RDB and myocardial scintigraphy by a discriminant function with specificity/sensitivity of 80%, are relevant parameters. Accurate diagnosis of latent pulmonary hypertension requires right heart catheterisation. The domain of non-invasive diagnosis is screening and therapy monitoring of pulmonary hypertension, or if right heart catheterisation is contraindicated.

摘要

在168例慢性阻塞性肺疾病(COPD)患者中,研究了无创参数升高在预测肺动脉高压方面的证据。用力肺活量(FVC)、蒂夫诺试验(FEV1)、氧分压、X线确定的肺动脉右降支(RDB)直径、心肌闪烁显像以及右心室射血分数在有和没有肺动脉高压的患者之间显示出显著差异。它们单独一项都不能准确预测肺动脉压力,只有联合使用无创参数才有用。在无创诊断导管插入术中,我们建议使用一个回归函数,该函数包括FEV1、FVC和RDB,确定的特异性为80%,敏感性为75%。为了根据肺动脉压力正常和升高对患者进行分类,通过特异性/敏感性为80%的判别函数得出的FEV1、RDB和心肌闪烁显像,是相关参数。隐匿性肺动脉高压的准确诊断需要右心导管插入术。无创诊断的领域是肺动脉高压的筛查和治疗监测,或者在右心导管插入术禁忌时使用。

相似文献

1
[Noninvasive diagnosis of pulmonary hypertension in patients with COPD using regression and discriminant analysis].[利用回归分析和判别分析对慢性阻塞性肺疾病患者肺动脉高压进行无创诊断]
Z Gesamte Inn Med. 1993 Nov;48(11):538-43.
2
[Prediction of pulmonary hypertension from simple, noninvasive parameters using discriminant analysis].[使用判别分析从简单无创参数预测肺动脉高压]
Z Erkr Atmungsorgane. 1985;164(3):284-7.
3
[Course study of pulmonary artery pressure in patients with chronic obstructive bronchitis].[慢性阻塞性支气管炎患者肺动脉压的病程研究]
Z Erkr Atmungsorgane. 1985;164(1):67-73.
4
Relation of noninvasive parameters and pulmonary artery mean pressure in patients with chronic obstructive lung disease.慢性阻塞性肺疾病患者无创参数与肺动脉平均压的关系
Clin Physiol Biochem. 1988;6(2):106-16.
5
[Influence of pulmonary hemodynamics on right ventricular ejection fraction in chronic obstructive pulmonary disease].[肺血流动力学对慢性阻塞性肺疾病患者右心室射血分数的影响]
Pneumologie. 1999 May;53(5):249-54.
6
[Possibilities of using non-invasive techniques to predict pulmonary arterial pressure in chronic respiratory diseases].
Pol Tyg Lek. 1991;46(22-23):436-9.
7
[M-mode echocardiography in the diagnosis of pulmonary arterial hypertension in chronic respiratory disorders].[M型超声心动图在慢性呼吸系统疾病肺动脉高压诊断中的应用]
Rev Mal Respir. 1987;4(2):77-84.
8
[Value of classical and new criteria of electrocardiography in diagnosis of hypoxic cor pulmonale evaluated by hemodynamics tests].[通过血流动力学检测评估心电图经典及新诊断标准在低氧性肺心病诊断中的价值]
Pol Merkur Lekarski. 1997 Aug;3(14):68-70.
9
Screening of pulmonary hypertension in chronic obstructive pulmonary disease and silicosis by discriminant functions.通过判别函数筛查慢性阻塞性肺疾病和矽肺中的肺动脉高压
Eur Respir J. 1992 Apr;5(4):444-51.
10
Right heart haemodynamic values and respiratory function test parameters in chronic smokers.
East Mediterr Health J. 2004 Jan-Mar;10(1-2):90-5.